4//SEC Filing
ELAN PHARMACEUTICAL INVESTMENTS LTD 4
Accession 0000950162-04-000498
CIK 0000810084other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 3:43 PM ET
Size
9.8 KB
Accession
0000950162-04-000498
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-13$3.00/sh−2,500$7,500→ 2,439,936 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and directly by its wholly-owned subsidiary, Elan International Services, Ltd.
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
Related Parties
1- filerCIK 0001279105
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 3:43 PM ET
- Size
- 9.8 KB